Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2227

1.

Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low-dose growth hormone therapy.

Zheng X, Cheng Q, Long J, Wang Y, Gong L, Wei Q, Luo R, Liao K, Ren W.

Clin Endocrinol (Oxf). 2019 Feb 28. doi: 10.1111/cen.13958. [Epub ahead of print]

PMID:
30817014
2.

Auxological characteristics of pediatric patients with permanent or transient isolated growth hormone deficiency. Response to treatment and final height.

Villafuerte B, Barrio R, Martín-Frías M, Alonso M, Roldán B.

Endocrinol Diabetes Nutr. 2019 Feb 13. pii: S2530-0164(19)30020-5. doi: 10.1016/j.endinu.2018.11.007. [Epub ahead of print] English, Spanish.

PMID:
30772372
3.

Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.

Bianchi A, Giampietro A, Tartaglione L, Chiloiro S, Gentilella R, Bima C, Anile C, Olivi A, Pontecorvi A, De Marinis L.

J Neuroendocrinol. 2019 Feb 3:e12692. doi: 10.1111/jne.12692. [Epub ahead of print]

PMID:
30712287
4.
5.

Identifying Potentially Modifiable Factors Associated with Treatment Non-Adherence in Paediatric Growth Hormone Deficiency: A Systematic Review.

Graham S, Weinman J, Auyeung V.

Horm Res Paediatr. 2018;90(4):221-227. doi: 10.1159/000493211. Epub 2018 Dec 6. Review.

6.

Precocious or early puberty in patients with combined pituitary hormone deficiency due to POU1F1 gene mutation: case report and review of possible mechanisms.

Baş F, Abalı ZY, Toksoy G, Poyrazoğlu Ş, Bundak R, Güleç Ç, Uyguner ZO, Darendeliler F.

Hormones (Athens). 2018 Dec;17(4):581-588. doi: 10.1007/s42000-018-0079-4. Epub 2018 Nov 20. Review.

PMID:
30460459
7.

Long-Acting Growth Hormone Preparations in the Treatment of Children.

Lal RA, Hoffman AR.

Pediatr Endocrinol Rev. 2018 Sep;16(Suppl 1):162-167. doi: 10.17458/per.vol16.2018.lh.longactingghpreparation.

PMID:
30378794
8.

The prevalence and volumetry of pituitary cysts in children with growth hormone deficiency and idiopathic short stature.

Krasnow N, Pogostin B, Haigney J, Groh B, Weiler W, Tenner M, Kessler M, Frey M, Noto RA.

J Pediatr Endocrinol Metab. 2018 Nov 27;31(11):1267-1271. doi: 10.1515/jpem-2017-0437.

PMID:
30367806
9.

Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy.

Ajmal A, McKean E, Sullivan S, Barkan A.

Pituitary. 2018 Dec;21(6):624-630. doi: 10.1007/s11102-018-0918-y.

PMID:
30349995
10.

Growth Hormone Deficiency and Nonalcoholic Fatty Liver Disease with Insights from Humans and Animals: Pediatric Implications.

Henry RK.

Metab Syndr Relat Disord. 2018 Oct 20. doi: 10.1089/met.2018.0056. [Epub ahead of print]

PMID:
30346875
11.

Gender-Dependent Growth and Insulin-Like Growth Factor-1 Responses to Growth Hormone Therapy in Prepubertal Growth Hormone-Deficient Children.

Witkowska-Sędek E, Rumińska M, Majcher A, Pyrżak B.

Adv Exp Med Biol. 2019;1133:65-73. doi: 10.1007/5584_2018_284.

PMID:
30338487
12.

Growth hormone treatment of Canadian children: results from the GeNeSIS phase IV prospective observational study.

Deal C, Kirsch S, Chanoine JP, Lawrence S, Cummings E, Rosolowsky ET, Marks SD, Jia N, Child CJ; GeNeSIS National Board on behalf of the GeNeSIS Canada Investigators.

CMAJ Open. 2018 Sep 10;6(3):E372-E383. doi: 10.9778/cmajo.20180020. Print 2018 Jul-Sep.

13.

Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).

Pfäffle R, Land C, Schönau E, Holterhus PM, Ross JL, Piras de Oliveira C, Child CJ, Benabbad I, Jia N, Jung H, Blum WF.

Horm Res Paediatr. 2018;90(3):169-180. doi: 10.1159/000492397. Epub 2018 Sep 10.

PMID:
30199857
14.

Panhypopituitarism Without GH Replacement: About Insulin Sensitivity, CRP Levels, and Metabolic Syndrome.

Castillo AR, Zantut-Wittmann DE, Neto AM, Jales RM, Garmes HM.

Horm Metab Res. 2018 Sep;50(9):690-695. doi: 10.1055/a-0649-8010. Epub 2018 Sep 5.

PMID:
30184563
15.

Impaired repletion of intramyocellular lipids in patients with growth hormone deficiency after a bout of aerobic exercise.

Loher H, Jenni S, Bucher J, Krüsi M, Kreis R, Boesch C, Christ E.

Growth Horm IGF Res. 2018 Oct - Dec;42-43:32-39. doi: 10.1016/j.ghir.2018.08.001. Epub 2018 Aug 17.

PMID:
30153529
16.

Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).

Boekhoff S, Bogusz A, Sterkenburg AS, Eveslage M, Müller HL.

Eur J Endocrinol. 2018 Oct 12;179(5):331-341. doi: 10.1530/EJE-18-0505.

PMID:
30139824
17.

A will and a way to fund medicines for rare diseases: the story of human growth hormone replacement for adults with growth hormone deficiency.

Lipworth W, Ambler G, Burt MG, Fairchild J, Inder WJ, Werther G, Ho K.

Intern Med J. 2018 Aug;48(8):999-1002. doi: 10.1111/imj.13943. Review.

PMID:
30133980
18.

Racial/Ethnic Disparities in US Pediatric Growth Hormone Treatment.

Grimberg A, Lindberg A, Wajnrajch M, Cucchiara AJ, Camacho-Hübner C.

Horm Res Paediatr. 2018;90(2):102-108. doi: 10.1159/000491793. Epub 2018 Aug 21.

PMID:
30130795
19.

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study.

Viala M, Chiba A, Thezenas S, Delmond L, Lamy PJ, Mott SL, Schroeder MC, Thomas A, Jacot W.

BMC Cancer. 2018 Jul 30;18(1):770. doi: 10.1186/s12885-018-4686-x.

20.

Resistance exercise alone improves muscle strength in growth hormone deficient males in the transition phase.

Amer NM, Modesto MJ, Dos Santos CD, Erichsen O, Mascarenhas LPG, Nesi-França S, Marques-Pereira R, De Lacerda L.

J Pediatr Endocrinol Metab. 2018 Aug 28;31(8):887-894. doi: 10.1515/jpem-2017-0369.

PMID:
30052519

Supplemental Content

Loading ...
Support Center